IMCR

Immunocore Holdings Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 7/10
  • Momentum↓ 4/10
Immunocore Holdings sales and earnings growth
IMCR Growth
Good
  • Revenue Y/Y↑ 28.10%
  • EPS Y/Y↑ 40.00%
  • FCF Y/Y↓ -84.94%
Immunocore Holdings gross and profit margin trends
IMCR Profitability
Neutral
  • Gross margin ↑ 99.30%
  • EPS margin↓ -7.70%
  • ROIC↓ -1.40%
Immunocore Holdings net debt vs free cash flow
IMCR Risk
Great
  • Debt / Equity↓ 1.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -0.7

Immunocore Holdings stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗